The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Man against machine reloaded: performance of a market-approved convolutional neural network in classifying a broad spectrum of skin lesions in comparison with 96 dermatologists working under less artificial conditions
Open accessAbstract
BACKGROUND Convolutional neural networks (CNNs) efficiently differentiate skin lesions by image analysis. Studies comparing a market-approved CNN in a broad range of diagnoses to dermatologists working under less artificial conditions are lacking. MATERIALS AND METHODS One hundred cases of pigmented/non-pigmented skin cancers and benign lesions were used for a two-level reader study in 96 dermatologists (level I: dermoscopy only; level II: clinical close-up images, dermoscopy, and textual information). Additionally, dermoscopic images were classified by a CNN approved for the European market as a medical device (Moleanalyzer Pro, FotoFinder Systems, Bad Birnbach, Germany). Primary endpoints were the sensitivity and specificity of the CNN's dichotomous classification in comparison with the dermatologists' management decisions. Secondary endpoints included the dermatologists' diagnostic decisions, their performance according to their level of experience, and the CNN's area under the curve (AUC) of receiver operating characteristics (ROC). RESULTS The CNN revealed a sensitivity, specificity, and ROC AUC with corresponding 95% confidence intervals (CI) of 95.0% (95% CI 83.5% to 98.6%), 76.7% (95% CI 64.6% to 85.6%), and 0.918 (95% CI 0.866-0.970), respectively. In level I, the dermatologists' management decisions showed a mean sensitivity and specificity of 89.0% (95% CI 87.4% to 90.6%) and 80.7% (95% CI 78.8% to 82.6%). With level II information, the sensitivity significantly improved to 94.1% (95% CI 93.1% to 95.1%; P < 0.001), while the specificity remained unchanged at 80.4% (95% CI 78.4% to 82.4%; P = 0.97). When fixing the CNN's specificity at the mean specificity of the dermatologists' management decision in level II (80.4%), the CNN's sensitivity was almost equal to that of human raters, at 95% (95% CI 83.5% to 98.6%) versus 94.1% (95% CI 93.1% to 95.1%); P = 0.1. In contrast, dermatologists were outperformed by the CNN in their level I management decisions and level I and II diagnostic decisions. More experienced dermatologists frequently surpassed the CNN's performance. CONCLUSIONS Under less artificial conditions and in a broader spectrum of diagnoses, the CNN and most dermatologists performed on the same level. Dermatologists are trained to integrate information from a range of sources rendering comparative studies that are solely based on one single case image inadequate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dermatologist-level classification of skin cancer with deep neural networks
Esteva, A., Kuprel, B., Novoa, R. A., Ko, J., Swetter, S. M., Blau, H. M., & Thrun, S. (2017) · Nature · doi:10.1038/nature21056 · Cited by 14,362
Tschandl, P., Codella, N., Akay, B. N., Argenziano, G., Braun, R. P., Cabo, H., Gutman, D., Halpern, A., Helba, B., Hofmann-Wellenhof, R., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30333-x · Cited by 555
Self-citationTeledermatology for the Diagnosis and Management of Skin Cancer: A Systematic Review
Finnane, A., Dallest, K., Janda, M., & Soyer, H. P. (2017) · JAMA Dermatology · doi:10.1001/jamadermatol.2016.4361 · Cited by 257
Cited by
Goyal, M., Knackstedt, T., Yan, S., & Hassanpour, S. (2020) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2020.104065 · Cited by 428
Daneshjou, R., Smith, M. P., Sun, M. D., Rotemberg, V., & Zou, J. (2021) · JAMA Dermatology · doi:10.1001/jamadermatol.2021.3129 · Cited by 403
Designing deep learning studies in cancer diagnostics
Kleppe, A., Skrede, O.-J., De Raedt, S., Liestøl, K., Kerr, D. J., & Danielsen, H. E. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-020-00327-9 · Cited by 316
Scheetz, J., Rothschild, P., McGuinness, M., Hadoux, X., Soyer, H. P., Janda, M., Condon, J. J. J., Oakden-Rayner, L., Palmer, L. J., Keel, S., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-84698-5 · Cited by 273
Jones, O. T., Matin, R. N., van der Schaar, M., Prathivadi Bhayankaram, K., Ranmuthu, C. K. I., Islam, M. S., Behiyat, D., Boscott, R., Calanzani, N., Emery, J., et al. (2022) · The Lancet Digital Health · doi:10.1016/s2589-7500(22)00023-1 · Cited by 272
Metadata
- Authors
- Haenssle, H. A., Fink, C., Toberer, F., Winkler, J., Stolz, W., Deinlein, T., Hofmann-Wellenhof, R., Lallas, A., Emmert, S., Buhl, T., Zutt, M., Blum, A., Abassi, M. S., Thomas, L., Tromme, I., Tschandl, P., Enk, A., Rosenberger, A., Alt, C., Bachelerie, M., Bajaj, S., Balcere, A., Baricault, S., Barthaux, C., Beckenbauer, Y., Bertlich, I., Blum, A., Bouthenet, M.-F., Brassat, S., Marcel Buck, P., Buder-Bakhaya, K., Cappelletti, M.-L., Chabbert, C., De Labarthe, J., DeCoster, E., Deinlein, T., Dobler, M., Dumon, D., Emmert, S., Gachon-Buffet, J., Gusarov, M., Hartmann, F., Hartmann, J., Herrmann, A., Hoorens, I., Hulstaert, E., Karls, R., Kolonte, A., Kromer, C., Lallas, A., Le Blanc Vasseux, C., Levy-Roy, A., Majenka, P., Marc, M., Bourret, V. M., Michelet-Brunacci, N., Mitteldorf, C., Paroissien, J., Picard, C., Plise, D., Reymann, V., Ribeaudeau, F., Richez, P., Roche Plaine, H., Salik, D., Sattler, E., Schäfer, S., Schneiderbauer, R., Secchi, T., Talour, K., Trennheuser, L., Wald, A., Wölbing, P., & Zukervar, P.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2020-01
- Volume
- 31
- Issue
- 1
- Pages
- 137-143
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W3000396219
- Cited by
- 236
- References
- 3
- FWCI
- 10.91
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Man against machine reloaded: performance of a market-approved convolutional neural network in classifying a broad spectrum of skin lesions in comparison with 96 dermatologists working under less artificial conditions. https://app.cochat.ai/papers/10.1016/j.annonc.2019.10.013
- The paper
- Haenssle, H. A., Fink, C., Toberer, F., Winkler, J., Stolz, W., Deinlein, T., Hofmann-Wellenhof, R., Lallas, A., Emmert, S., Buhl, T., Zutt, M., Blum, A., Abassi, M. S., Thomas, L., Tromme, I., Tschandl, P., Enk, A., Rosenberger, A., Alt, C., . . . Zukervar, P. (2020). Man against machine reloaded: performance of a market-approved convolutional neural network in classifying a broad spectrum of skin lesions in comparison with 96 dermatologists working under less artificial conditions. Annals of Oncology. https://doi.org/10.1016/j.annonc.2019.10.013
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.